Invesco Ltd. (IVZ) fair value analysis
S&P 500 · Updated 2026-10-19
IVZ price how computed
Forward Fair Value verdict
Fairly valuedIVZ is trading at within about 10% of estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $29.51
- Sector
- Financial Services
- 12-month range
- $22.44–$33.31
- Market cap
- $13B
- From 52-week high
- -11.4%
- Shares outstanding
- 442M
- Rank in Financial Services by discount to fair value
- #63 of 167
Last price is our 2026-10-19 weekly price; the chart runs through 2026-10-16.
Invesco Ltd. is a global investment management company that provides asset management services including investment products, portfolio management, and financial advisory services to institutional and individual clients. The company operates in multiple countries across North America, Europe, Asia-Pacific, and other regions around the world.
IVZ currently ranks #63 of 167 Financial Services stocks by discount to fair value. It has screened as Fairly valued for 14 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $13B
- P/E (trailing)
- 12x
- Revenue (TTM)
- $6.9B
- Net margin
- -0.9%
- EPS (TTM)
- $2.51
- Gross margin
- 99.6%
- Debt / equity
- 0.13
- Revenue growth (3-yr avg)
- 8.9%
- Shares outstanding
- 442M
Derived indicators how computed
- Quality grade
- B
- Margin trend
- Expanding
- 52-week position
- The upper-middle quarter of its range
Technicals how computed
- RSI (14-day)
- 36 · neutral
- 50-day average
- $31.22
- 200-day average
- $27.95
- Moving-average state
- 50-day above 200-day (golden cross state); price between the averages
Dividends how computed
- Paid, last 12 months
- $0.85 per share (4 payments)
- Yield on last price
- 2.88%
- Consecutive years of increases
- 1
- Last ex-dividend date
- 2026-08-14
- Last payment date
- 2026-09-02
Earnings how computed
- Next earnings report
- 2026-10-27 (pre-market)
- Last 8 quarters vs consensus
- 6 beat, 2 missed
- Quarter by quarter
- 2026-06 ▲ beat (+6.0%)
2026-03 ▼ miss (-1.7%)
2025-12 ▲ beat (+6.9%)
2025-09 ▲ beat (+38.6%)
2025-06 ▼ miss (-10.0%)
2025-03 ▲ beat (+12.8%)
2024-12 ▲ beat (+10.6%)
2024-09 ▲ beat (+2.3%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 5 buy · 9 hold · 0 sell (14 analysts)
- Consensus lean
- Hold-leaning
- Consensus price target
- $34.6
- Target vs last price
- +17.2%
What our data shows for IVZ
- Our model validated 17 trailing price-to-earnings windows for IVZ, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $22.44–$33.31.
- The 14-day relative strength index sits at a neutral 36.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for IVZ
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent IVZ news
TickrTrends' derived news-sentiment signal for IVZ is currently leaning positive, computed from recent coverage.
- The Surprising Case For Investing When The Fed's Raising Rates (seekingalpha.com, 2026-10-20)
TickrTrends take: IVZ operates in the Financial Services sector where rate environments significantly influence business dynamics and valuation multiples. The headline's discussion of investment opportunities during Federal Reserve rate increases is relevant context for evaluating IVZ, as financial services companies often experience shifting valuations based on interest rate movements. With TickrTrends currently assessing IVZ as fairly valued, investors should monitor how changes in the rate environment impact the company's earnings power and whether the current valuation remains appropriate as monetary policy evolves. - Are We There Yet? Bull Market May Have More Miles (seekingalpha.com, 2026-10-19)
TickrTrends take: Invesco operates in an environment where market sentiment remains constructive, which could support asset flows and management fees for Financial Services firms positioned in the sector. Given TickrTrends' assessment of Invesco as fairly valued, investors focused on valuation metrics should monitor whether sustained market strength translates into revenue growth that justifies the current pricing. The relationship between equity market performance and asset management profitability will be a key factor for determining whether the fair value designation remains appropriate as market conditions evolve. - Invesco Ltd (IVZ) Shares Fall 3.4% -- GF Value Says Still Overvalued (gurufocus.com, 2026-10-14)
TickrTrends take: Invesco shares declined recently, yet TickrTrends currently assesses the company as fairly valued, suggesting the market decline may have brought pricing closer to intrinsic worth from a valuation perspective. The divergence between this assessment and the GF Value indicator's overvaluation call highlights how different valuation methodologies can produce varying conclusions about the same Financial Services company. Investors focused on valuation metrics should monitor whether further price movement narrows or widens the gap between these differing assessments.
More IVZ news
- Ten Asset Managers See $8.30 Trillion AUM Decline in September; Invesco (IVZ) Shows Modest Drop (gurufocus.com, 2026-10-14)
- Melexis: Transparency declaration by Invesco Ltd. (manilatimes.net, 2026-10-13)
- DBA: A Well-Rounded Commodity ETF, But With A K-1 (seekingalpha.com, 2026-10-12)
- Invesco Global Real Estate Income Fund Q2 2026 Commentary (ASRAX) (seekingalpha.com, 2026-09-24)
What people are saying
Follow the IVZ conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — IVZ's sector discount rank improved this week, moving from number 80 to number 68 among Financial Services companies. The company maintains a fairly valued assessment based on current metrics.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is IVZ stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), IVZ is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.
What is IVZ's TickrTrends verdict?
IVZ's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.
How does IVZ compare to other Financial Services stocks?
IVZ ranks #63 of 167 Financial Services stocks in TickrTrends' coverage by discount to fair value.
Is IVZ overbought or oversold?
IVZ's 14-day RSI is in neutral territory - neither overbought nor oversold.
Does IVZ pay a dividend?
Yes. IVZ paid $0.85 per share over the last twelve months (4 payments), a 2.88% yield on TickrTrends' last price, and has raised the annual total for 1 consecutive year. The last ex-dividend date was 2026-08-14.
When does IVZ report earnings next?
IVZ's next earnings report is scheduled for 2026-10-27 (pre-market), per the published earnings calendar.
Does IVZ usually beat earnings estimates?
Over its last 8 reported quarters IVZ beat the consensus estimate 6 times and missed 2 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about IVZ?
Of 14 analysts covering IVZ, 5 rate it a buy, 9 a hold and 0 a sell - hold-leaning, with a consensus price target of $34.6 (+17.2% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Financial Services
Head-to-head comparisons
IVZ vs BAC · IVZ vs CBOE · IVZ vs CVBF · IVZ vs LIFE · IVZ vs NMFC